茶碱缓释片联合舒利迭治疗中重度支气管哮喘的疗效评价

The clinical effect evaluation on Doxofylline combined with Seretide used in moderate and serious bronchial asthma

目的：探讨茶碱缓释片联合舒利迭治疗中重度支气管哮喘患者的临床效果。方法：120例中重度支气管哮喘患者被随机分为实验组（n=61）和对照组（n=59），两组均给予常规治疗，对照组给予舒利迭治疗，实验组给予茶碱缓释片联合舒利迭治疗。结果：两组在PaO2、PaCO2和SaO2等方面有显著性差异（P〈0．05），实验纽疗效显著优于对照纽。结论：对于中重度支气管哮喘患者，常规治疗结合茶碱缓释片争舒利迭联合用药，能显著改善临床效果，提高患者生活质量，是值得在临床上应用和推广的。

Objective： To explore the clinical effect of Doxofylline combined with Seretide used in moderate and serious bronchial asthma. Methods： 120 cases of patients with moderate and serious bronchial asthma were randomly divided into experimental group （n = 61） and control group （n =59）. Both groups were given routine therapy, control group was given therapy of Seretide, and experimental group was given therapy of DoxofyUine combined with Seretide. Results： The PaO2.PaCO2 and SaO2 in experimental group were significantly better than that in control group （p 〈 0.05）. Conclusion： For moderate and serious bronchial asthma patients, Doxofylline combined with Seretide on base of routine therapy, can enhance clinical effect and improve the life quality of patients significantly. So it deserved application and promotion in clinical work.